Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Derivative Financial Instruments

v2.4.0.8
Note 11 - Derivative Financial Instruments
3 Months Ended
Mar. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities Disclosure [Text Block]

11.      Derivative financial instruments


The Company entered into forward foreign exchange contracts to reduce its exposure to foreign exchange currency rate fluctuations related to forecasted Canadian dollar denominated payroll, rent and utility cash flows for fiscal 2014 and the first three months of fiscal 2015, and Mexican peso denominated payroll, rent and utility cash flows for fiscal 2014. These contracts were effective as hedges from an economic perspective, but did not meet the requirements for hedge accounting under ASC 815 “Derivatives and Hedging”. Accordingly, changes in the fair value of these contracts were recognized into net income in the consolidated statement of operations and comprehensive income (loss). The Company does not enter into forward foreign exchange contracts for trading or speculative purposes.


The following table presents a summary of the outstanding foreign currency forward contracts as at March 30, 2014:  


Currency

Buy/Sell

Foreign Currency Amount

 

Notional Contract Value in USD

 

Canadian Dollar

Buy

CAD 6,800

  $ 6,414  

Mexican Peso

Buy

MXN 233,647

  $ 18,000  

The unrealized gain recognized in earnings as a result of revaluing the instruments to fair value on March 30, 2014 was $92 (March 31, 2013 – $1,019) which was included in cost of sales in the consolidated statement of operations and comprehensive income (loss). The realized loss on these contracts was $450 (March 31, 2013 – realized gain $280), and is included as a component of cost of sales, in the consolidated statement of operations and comprehensive income (loss). Fair value was determined using the market approach with valuation based on market observables (Level 2 quantitative inputs in the hierarchy set forth under ASC 820 “Fair Value Measurements”).


The following table presents the fair value of the Company’s derivative instruments included in the consolidated balance sheet as at March 30, 2014: 


   

March 30,

       
   

2014

   

December 29, 2013

 

Prepaid Expenses and Other Assets

  $     $  

Accrued Liabilities

    (384 )     (476 )

Net fair value of derivative financial instruments

  $ (384 )   $ (476 )